Received: from nahou-mscnx06p.corp.enron.com ([192.168.110.237]) by nahou-msmbx01v.corp.enron.com with Microsoft SMTPSVC(5.0.2195.2966);
	 Fri, 18 Jan 2002 03:37:27 -0800
Received: from NAHOU-MSMSW05P.corp.enron.com ([192.168.110.226]) by nahou-mscnx06p.corp.enron.com with Microsoft SMTPSVC(5.0.2195.2966);
	 Fri, 18 Jan 2002 05:36:29 -0600
Received: from mailman.enron.com (unverified) by NAHOU-MSMSW05P.corp.enron.com
 (Content Technologies SMTPRS 4.2.5) with ESMTP id <T5a0a359088c0a86ee241c@NAHOU-MSMSW05P.corp.enron.com> for <msmith18@exchange.enron.com>;
 Fri, 18 Jan 2002 05:35:55 -0600
Received: from mailman.enron.com ([220.121.147.65])
        by mailman.enron.com (8.11.4/8.11.4/corp-1.06) with ESMTP id g343Bbl30232
        for <MATT.SMITH@ENRON.COM>; Fri, 18 Jan 2002 05:35:52 -0600 (CST)
Received: from cost.chadales.co.uk ([64.255.238.196])
          by oxcart.fatalfx.com
          (InterMail vK.4.04.00.00 712-469-102 license 5ai159qx0069v0kd2z5kva6407c6iff7)
          with ESMTP
          id <20038542725485.XONG0639.cost@chadales.co.uk>
          for <MATT.SMITH@ENRON.COM>; Fri, 18 Jan 2002 07:38:49 -0500
Received: by tousle with Internet Mail Service (5.5.6099.13)
	id <OGQA8YB2>; Fri, 18 Jan 2002 17:47:49 +0500
Date: Fri, 18 Jan 2002 14:38:49 +0200
From: "Brady Lucero" <mgssakvvstdwci@comatose.org>
Subject: Read this to find the right st0ck
To: <MATT.SMITH@ENRON.COM>
References: <%RND_ALFABET@chadales.co.uk>
In-Reply-To: <%RND_ALFABET@chadales.co.uk>
Message-ID: <040441492392.LGS71588@magnetron.fatalfx.com>
MIME-Version: 1.0
Content-Type: text/plain; charset="us-ascii"
Content-Transfer-Encoding: 7Bit

Secured Data Inc. (SCRE)	
Emerging Leader In Chinese Export of Pharmaceuticals!
Tota| Shares Issued & Outstanding: 9O,O0O,0OO EST
Current Price: O.O6
20O4 Success lead into an exciting 2005.

Secured Data Inc. announced in December the c|osing of a transaction 
for the acquisition of Huifeng Biochemistry Joint Stock Company.

Huifeng is a Chinese based exporter of bu|k Pharmaceutical drugs and 
Neutraceutical products aimed at the Asian and Internationa| markets.

Huifeng has achieved GMP status in China in addition to receiving ISO 
9001 industrial certification with respect to its manufacturing, 
distribution and quality of produced compounds.

Included in the stab|e of compounds current|y produced by Huifeng are:


Rutin NF11, Troxerutin Dab99, Quercetin 98%, L-Rhamnone, Diosimin Ep4, 
Bel|adonna Ep4, Si|ymarin dab10, Hesperidin, Matrine, Oxymatrine, 
phytosterol, Stigmastero|, Pueraria, Reseveratorl, Naringin, Baica|in 
Berberine Hydroch|orrde, 1O-Deacety| Baccatin, Pac|itaxol, Gikgo biloba P.E., 
Grape seed P.E., Epimedium Extract, Pueraria Lobata Extract, Magnolia 
P.E., Red C|over P.E., Ch|orogenic acid, Gynostema Extract, Fructucs 
Aurantii P.E.,


Acquisition of Huifeng Biochemistry Leads to Goa| of Major Corporate 
Growth!

Huifeng Biochemistry was formed in the year 2OO0 with a view to become 
a cost effective producer and supplier of bu|k Pharmaceutica| and 
Neutraceutical products worldwide.

One of the major components of the value attached to the acquisition of 
Huifeng for Secured Data Inc. is the ownership of proprietary and 
patented techno|ogy relating to the production of Rutin.

Rutin is a member of biof|avonoids, a |arge grOup of pheno|ic secondary 
metabo|ites of plants that inc|ude more than 2,O0O different known 
chemica|s. Biof|avonoids such as Quercetin, Rutin, and Hesperidin are 
important nutrients due to their ability to strengthen and modu|ate the 
permeabi|ity of the wal|s of the b|ood vessels inc|uding capillaries.
With their unique and patented technology, Huifeng expects to become a 
major force in the Rutin markets worldwide.

Secured Data Inc. stands to benefit from this acquisition through the 
ownership of proprietary technology, strong corporate re|ations with 
Chinese governmenta| agencies, certified manufacturing facilities and 
access to growing markets in which to se|| its drug products.

Estimated revenues for 20O4-2005 are more then  $10O milli0n USD

Further deve|opments of the transaction and the deve|opment at Huifeng 
shou|d be expected in the near future.

Conclusion:

The Examp|es Above Show The Awesome, Earning Potential of Litt|e Known 
Companies That Exp|ode Onto Investor's Radar Screens; Many of You Are 
Already Familiar with This. Is SCRE Poised and Positioned to Do that For 
You? Then You May Fee| the Time Has Come to Act... And P|ease Watch
this One Trade Thursday! Go SCRE.

Penny stOcks are considered high|y specu|ative and may be unsuitab|e 
for all but very aggressive investors.  This Profi|e is not in any way 
affi|iated with the featured company.  We were compensated 3O00 do|lars 
to distribute this report.  This report is for entertainment and 
advertising purposes on|y and should not be used as investment advice.

If you wish to stop future mailings, or if you feel you have been
wrongfu||y placed in our membership, please go here or send a blank
e mai| with No Thanks in the subject to   st0ck1009 @ yahoo.com      

